Improving urine protein testing after kidney injury
Improving proteinuria testing and management after acute kidney injury
This study is looking at how to make it easier for doctors to test protein levels in urine after someone has had an acute kidney injury, so they can better manage kidney health and help patients get the care they need.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-11143660 on NIH RePORTER |
What this research studies
This research focuses on enhancing the testing and management of protein levels in urine following acute kidney injury (AKI). It aims to identify barriers and facilitators to timely proteinuria testing, which is crucial for predicting long-term kidney health. The study will involve qualitative methods and analysis of electronic health records to develop strategies that encourage follow-up care and improve patient outcomes. By integrating innovative platforms, the research seeks to increase awareness and adherence to proteinuria management among healthcare providers.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have recently suffered from acute kidney injury and are at risk for subsequent kidney function loss.
Not a fit: Patients who have not experienced acute kidney injury or those with chronic kidney disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better monitoring and management of kidney health, reducing the risk of long-term complications for patients who have experienced acute kidney injury.
How similar studies have performed: Previous research has shown that improving follow-up care and testing for proteinuria can lead to better patient outcomes, indicating that this approach has potential for success.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Kwong, Yuenting Diana — University of California, San Francisco
- Study coordinator: Kwong, Yuenting Diana
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.